Dermatitis, Atopic: all 1,444 studies

Page 12 of 15. Open to participants first (253), then studies with results posted, then the rest; newest registration first within each.

• Pharmacodynamics of Omiganan BID in Patients With Atopic DermatitisCompletedNCT03091426Phase 2
• Sleep & Quality of Life Evaluation of Patients With Atopic Dermatitis Based on E-diary on a Smartphone Application and ActigraphyCompletedNCT03090178Not applicable
• A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic DermatitisCompletedNCT03089229Phase 1/2
• Treatment of Atopic Dermatitis by a Full-Body Blue Light DeviceCompletedNCT03085303Not applicable
• Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic DermatitisCompletedNCT03083730Not applicable
• Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic DermatitisCompletedNCT03059693Phase 1/2
• Efficacy of Combining Topical Antibiotic/Steroid/Moisturizer Therapy Compared to Active Comparator in Atopic Dermatitis.Status unknownNCT03052348Not applicable
• Internet-based Mindfulness and Exposure Treatment for Atopic DermatitisCompletedNCT03051958Not applicable
• Asthma and Atopic Dermatitis Validation of PROMIS Pediatric InstrumentsCompletedNCT03051347Not applicable
• Study of Dupilumab Auto-injector Device When Used by Patients With Atopic DermatitisCompletedNCT03050151Phase 1
• Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic DermatitisCompletedNCT03047954Phase 3
• Efficacy of Fermented Rice Flour for the Treatment of Atopic Dermatitis: Randomized, Double-blind Controlled TrialStatus unknownNCT03042624Not applicable
• Beginning Assessment of Cutaneous Treatment Efficacy of Roseomonas in Atopic DermatitisCompletedNCT03018275Phase 1/2
• A Trial of a Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic DermatitisWithdrawnNCT03000595Phase 2
• CAPTAIN-AD: Clinical Study of AmorePacific's TRPV1 Antagonist in Atopic DermatitisCompletedNCT02965118Phase 3
• Study of RVT-501 in Adult and Adolescent Subjects With Atopic DermatitisCompletedNCT02950922Phase 2
• DMT210 Topical Gel in the Treatment of Atopic DermatitisCompletedNCT02949960Phase 2
• Effects of Lactobacillus Reuteri Plus Vitamin D3 in Children With Atopic DermatitisCompletedNCT02945683Not applicable
• Trial on Vascular Inflammation in Atopic DermatitisCompletedNCT02926807
• Effectiveness of a Combined Dermatological Treatment in Children With Atopic DermatitisCompletedNCT02920411Not applicable
• A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and SpecialistsCompletedNCT02916888
• Narrowband Ultraviolet B Versus Narrowband Ultraviolet B Plus Ultraviolet A1 for Atopic EczemaCompletedNCT02915146Not applicable
• Effect of Oral Steroids on Skin Outcomes in Atopic DermatitisTerminatedNCT02908698Not applicable
• Study of the Frequency and of the Regulatory Function of Positive T Lymphocytes Dual CD4CD8aa (DP8a) Specific to a Bacteria of the Intestinal Microbiota (Faecalibacterium Prausnitzii) in Atopic Dermatitis, Asthma and Allergic RhinitisCompletedNCT02908360
• Atopic Dermatitis in Atopy Predisposed InfantsCompletedNCT02906475Not applicable
• Efficacy, Safety and Dose Finding Trial of Topical Jaungo Application in Atopic Dermatitis PatientsCompletedNCT02900131Phase 2
• Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic DermatitisCompletedNCT02896101Phase 3
• Maternal Key Nutritional Factors and Offspring's Atopic Dermatitis (MKNFOAD)CompletedNCT02889081
• Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic DermatitisCompletedNCT02888704Phase 1
• Animal Allergy in Korean Veterinary ResearcherCompletedNCT02866864
• Topical Solution for the Treatment of Atopic DermatitisCompletedNCT02865356Phase 2
• Antipruritic Effect of Acupuncture in Patients With Atopic DermatitisCompletedNCT02844452Not applicable
• The Effect of Gladskin on Disease Severity and the Skin Microbiome, Including Staphylococcus Aureus, in Patients With Atopic DermatitisCompletedNCT02840955Not applicable
• Study of Autologous Total Immunoglobulin G Therapy for Atopic DermatitisCompletedNCT02835170Phase 2/3
• Texting Atopic Dermatitis Patients to Optimize Learning and EASI ScoresCompletedNCT02779426Not applicable
• Evaluating Results of Regularly Applied Emollient - Spray in Atopic Dermatitis TherapyStatus unknownNCT02763722Not applicable
• A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic DermatitisCompletedNCT02757729Phase 2
• A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic DermatitisCompletedNCT02748993Phase 1/2
• First in Human of Single and Multiple Doses of MOR106CompletedNCT02739009Phase 1
• Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic DermatitisCompletedNCT02732314Phase 4
• Efficacy of the "Атопик Soothing Cream" in Children With Mild to Moderate Atopic DermatitisCompletedNCT02716181Not applicable
• Behavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema PatientsTerminatedNCT02713035Not applicable
• Identification of Epidermal Signatures in Patients With Atopic DermatitisStatus unknownNCT02680405
• Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and OlderWithdrawnNCT02677636Phase 3
• Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and OlderWithdrawnNCT02677610Phase 3
• Indigo Naturalis in Treating Atopic Dermatitis TopicallyCompletedNCT02669888Phase 2
• Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)CompletedNCT02647086Phase 1
• Skin Irritation Study of GSK2894512 CreamCompletedNCT02637206Phase 1
• A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 MonthsTerminatedNCT02634905Not applicable
• An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical CorticosteroidsCompletedNCT02627989
• Curing Atopic Dermatits in Children With a Commerical Medical Device and Maintaining Healthy Skin by Using a New Cosmetic ProductCompletedNCT02615561Not applicable
• Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)Active, not recruitingNCT02612454Phase 3
• To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)CompletedNCT02601703Phase 3
• The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic DermatitisCompletedNCT02594969Not applicable
• A Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult SubjectsCompletedNCT02590289Phase 1
• Intervention Study to Evaluate a Probiotic in Mild Atopic Dermatitis Young PatientsCompletedNCT02585986Not applicable
• A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic DermatitisCompletedNCT02583022Phase 2
• Bathing Additives in Pediatric Atopic DermatitisTerminatedNCT02582788Not applicable
• Safety, Tolerability, Pharmacokinetics and Efficacy of WOL071-007 in Atopic Dermatitis PatientsCompletedNCT02576093Phase 1
• Atopy Patch Test in Children With Atopic DermatitisCompletedNCT02552979
• PRAgmatic Trial in Atopic Dermatitis Testing Long-term Control Effectiveness of New Phototherapy Regimen During Winter Coupled With Oral Vitamin D Supplementation vs. PlaceboCompletedNCT02537509Phase 2
• Does Treatment With Montelukast Improve Symptoms of Atopic Dermatitis in Children?CompletedNCT02534467Phase 4
• Wool Clothing for the Management of Childhood Atopic DermatitisCompletedNCT02534428Not applicable
• The Natural History of Atopic Disease in Thai Children and Association With Atopic MarchCompletedNCT02532920
• Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in ChildrenCompletedNCT02519556Phase 4
• An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)CompletedNCT02496546Phase 1
• Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic DermatitisCompletedNCT02475447Phase 2
• Pharmacokinetic Study of Topical GSK2894512 CreamCompletedNCT02466152Phase 1
• A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic DermatitisCompletedNCT02465606Phase 2
• Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic DermatitisCompletedNCT02456480Phase 2
• Preventing Atopic Dermatitis and ALLergies in ChildrenActive, not recruitingNCT02449850Not applicable
• Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis PatientsCompletedNCT02426359Phase 2
• A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 CreamCompletedNCT02411162Phase 1
• The Role of Filaggrin and FADS Genes on the Concentrations of PUFA Towards Its Effect on Atopic Dermatitis in InfantsCompletedNCT02401178
• Topical Treatment With Fresh Human Milk Versus Emollient on Atopic Eczema Spots in Young ChildrenCompletedNCT02381028Not applicable
• A Study to Assess the Safety, Tolerability, PK and PD of AM1030-CREAM in Patients With Atopic DermatitisCompletedNCT02379910Phase 1/2
• A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)CompletedNCT02376049Phase 1
• Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic DermatitisTerminatedNCT02369432Early Phase 1
• A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic DermatitisCompletedNCT02345928Phase 1
• The Effectiveness of Tailored Messages on the Usage of Emollient in Patients With Atopic DermatitisCompletedNCT02343861Not applicable
• A Study to Evaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy ParticipantsCompletedNCT02343783Early Phase 1
• A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic DermatitisCompletedNCT02340234Phase 2
• Cognitive Behavior Therapy for Atopic DermatitisCompletedNCT02302625Not applicable
• Role of Anti-IgE in Severe Childhood EczemaCompletedNCT02300701Phase 4
• Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic DermatitisStatus unknownNCT02286700Phase 3
• Treatment of Chronic Itch in Atopic Dermatitis (Eczema): Nerve FunctionCompletedNCT02268448Phase 1
• 0.005% Sodium Hypochlorite Final Rinse Solution in Atopic DermatitisWithdrawnNCT02241174Phase 1
• Photophoresis Versus Ciclosporine in Severe Atopic DermatitisCompletedNCT02226068Not applicable
• Study to Examine the Benefits of Fabric Made With Lyocell/Chitosan/Ceramide in the Treatment of Children With Mild to Moderate EczemaWithdrawnNCT02224950Not applicable
• Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)CompletedNCT02219633Phase 1
• Haut-Tief Patient Education on Psoriasis and EczemaStatus unknownNCT02205593Not applicable
• Taking Into Account the Patient/Parent Preference in the Galenic Choice in Atopic Dermatitis. Feasibility and Impact on Treatment AdherenceCompletedNCT02193230
• WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis PatientsCompletedNCT02182570Phase 3
• WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis PatientsCompletedNCT02182557Phase 3
• Effect of Holly Mangrove Shower Gel in Atopic Dermatitis PatientsCompletedNCT02178215Phase 3
• Study to Determine the Pharmacokinetics of Product 0405WithdrawnNCT02176577Phase 3
• Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric SubjectsWithdrawnNCT02176551Phase 3
• Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric SubjectsWithdrawnNCT02176538Phase 3
• Atopic Dermatitis Adherence StudyStatus unknownNCT02169986Not applicable
• Treatment of Atopic Dermatitis With Different Orders of Application of Locoid Lotion and Hylatopic Plus CreamCompletedNCT02153762Not applicable

← Dermatitis, Atopic overview